Eli Lilly and CompanyFinancials

Period:
Currency:
Units:
'85
'89
'93
'97
'01
'05
'09
'13
'17
'21
'25

Select different items in the table to generate charts

Income Statement
Dec 25
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Dec 19
Dec 18
Dec 17
Dec 16
Revenue
65,179
45,042.7
34,124.1
28,541.4
28,318.4
24,539.8
22,319.5
21,493.3
19,973.8
21,222.1
Revenue % Change
44.70%
32.00%
19.56%
0.79%
15.40%
9.95%
3.84%
7.61%
-5.88%
6.33%
Cost of Revenue
10,564
8,418.3
7,082.2
6,629.8
7,312.8
5,483.3
4,721.2
4,681.7
4,447.7
5,710.1
Gross Profit
54,615
36,624.4
27,041.9
21,911.6
21,005.6
19,056.5
17,598.3
16,811.6
15,526.1
15,512
Gross Profit % Change
49.12%
35.44%
23.41%
4.31%
10.23%
8.29%
4.68%
8.28%
0.09%
3.96%
Gross Profit Margin
83.79%
81.31%
79.25%
76.77%
74.18%
77.66%
78.85%
78.22%
77.73%
73.09%
R&D Expenses
13,337.5
10,990.6
9,313.4
7,190.8
6,930.7
5,976.3
5,595
5,051.2
5,096.2
5,310.3
Selling, General, & Admin Expenses
11,094
8,132.1
6,941.2
6,067.5
6,141.9
5,869.4
6,003.9
5,734.6
6,180.1
6,330.4
Other Expenses
487.5
Operating Income
29,696
17,501.7
10,787.3
8,653.3
7,933
7,210.8
5,999.4
6,025.8
4,249.8
3,871.3
Operating Income % Change
69.67%
62.24%
24.66%
9.08%
10.02%
20.19%
-0.44%
41.79%
9.78%
7.77%
Operating Income Margin
45.56%
38.86%
31.61%
30.32%
28.01%
29.38%
26.88%
28.04%
21.28%
18.24%
Total Other Income/Expenses Net
-3,965
-4,821.3
-4,232.7
-1,846.9
-1,777.5
19.1
-733.5
-2,345.7
-1,945
-497.3
Income Before Tax
25,729.9
12,680.4
6,554.6
6,806.4
6,155.5
7,229.9
5,265.9
3,680.1
2,304.8
3,374
Income Before Tax % Change
102.91%
93.46%
-3.70%
10.57%
-14.86%
37.30%
43.09%
59.67%
-31.69%
20.93%
Income Before Tax Margin
39.48%
28.15%
19.21%
23.85%
21.74%
29.46%
23.59%
17.12%
11.54%
15.90%
Income Tax Expense
5,091.6
2,090.4
1,314.2
561.6
573.8
1,036.2
628
529.5
2,391.2
636.4
Net Income
20,638.3
10,590
5,240.4
6,244.8
5,581.7
6,193.7
8,318.4
3,232
-204.1
2,737.6
Net Income % Change
94.88%
102.08%
-16.08%
11.88%
-9.88%
-25.54%
157.38%
-1683.54%
-107.46%
13.67%
Net Income Margin
31.66%
23.51%
15.36%
21.88%
19.71%
25.24%
37.27%
15.04%
-1.02%
12.90%
Weighted Avg. Shares Out
898
900.61
899.38
950.18
953.65
956.59
957.53
1,027.72
1,052.02
1,100.88
EPS
15.59
11.76
5.83
6.57
5.85
6.47
8.69
3.14
-0.19
2.49
EPS % Change
32.57%
101.72%
-11.26%
12.31%
-9.58%
-25.55%
176.75%
-1752.63%
-107.63%
14.22%
Weighted Avg. Shares Out Dil
898
904.06
903.28
950.18
953.65
956.59
957.53
1,033.67
1,052.02
1,100.88
EPS Diluted
22.95
11.71
5.80
6.57
5.85
6.47
8.69
3.13
-0.19
2.49
Diluted EPS % Change
95.99%
101.90%
-11.72%
12.31%
-9.58%
-25.55%
177.64%
-1747.37%
-107.63%
14.22%
Net Income
20,638.3
10,590
5,240.4
6,244.8
5,581.7
6,193.7
8,318.4
3,232
-204.1
2,737.6
Income Tax Expense
5,091.6
2,090.4
1,314.2
561.6
573.8
1,036.2
628
529.5
2,391.2
636.4
Interest Income
153.3
175.2
173.6
62.8
25.4
33
80.4
159.3
166.4
108.7
Interest Expense
795.3
780.6
485.9
331.6
339.8
359.6
400.6
242.5
225
185.2
EBIT
25,087.9
12,075
6,242.3
6,537.6
5,841.1
6,903.3
4,945.7
3,596.9
2,246.2
3,297.5
EBIT % Change
107.77%
93.44%
-4.52%
11.92%
-15.39%
39.58%
37.50%
60.13%
-31.88%
21.42%
EBIT Margin
38.49%
26.81%
18.29%
22.91%
20.63%
28.13%
22.16%
16.73%
11.25%
15.54%
Depreciation & Amortization
1,563.5
1,766.6
1,527.3
1,522.5
1,547.6
1,323.9
1,232.6
1,609
1,567.3
1,496.6
EBITDA
26,651.4
13,841.6
7,769.6
8,060.1
7,388.7
8,227.2
6,178.3
5,205.9
3,813.5
4,794.1
EBITDA % Change
92.55%
78.15%
-3.60%
9.09%
-10.19%
33.16%
18.68%
36.51%
-20.45%
15.70%
EBITDA Margin
40.89%
30.73%
22.77%
28.24%
26.09%
33.53%
27.68%
24.22%
19.09%
22.59%